A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial

• Published in: BMC cancer Vol. 22; no. 1; p. 305
• Main Authors: den Dekker, Bianca M, Christenhusz, Anke, van Dalen, Thijs, Jongen, Lisa M, van der Schaaf, Margreet C, Dassen, Anneriet E, Pijnappel, Ruud M
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 22.03.2022; BioMed Central; BMC
• Subjects: Adolescent; Adult; Breast cancer; Breast conserving surgery; Breast Neoplasms - diagnosis; Breast Neoplasms - surgery; Cancer; Cancer screening; Carcinoma; Care and treatment; Cohort analysis; Diagnosis; Feasibility Studies; Female; Health aspects; Humans; Identification documents; Invasiveness; Lesions; Localization; Lumpectomy; Mammography; Margins of Excision; Mastectomy, Segmental - methods; Medical screening; Patient outcomes; Patients; Prospective Studies; Questionnaires; R&D; Radio frequency identification; Radio frequency identification (RFID); Radio Frequency Identification Device; Radio-tagging; Radiofrequency identification; Research & development; RFID; Risk factors; Semiconductors; Statistical analysis; Study Protocol; Surgeons; Surgery; Surgical outcomes; Ultrasonic imaging; Usability; Young Adult; Netherlands; Breast conserving surgery; RFID; Breast cancer; Localization; Radiofrequency identification
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-022-09394-7

Breast cancer screening and improving imaging techniques have led to an increase in the detection rate of early, nonpalpable breast cancers. For early breast cancer, breast conserving surgery is an effective and safe treatment. Accurate intraoperative lesion localization during breast conserving surgery is essential for adequate surgical margins while sparing surrounding healthy tissue to achieve optimal cosmesis. Preoperative wire localization and radioactive seed localization are accepted standard methods to guide surgical excision of nonpalpable breast lesions. However, these techniques present significant limitations. Radiofrequency identification (RFID) technology offers a new, nonradioactive method for localizing nonpalpable breast lesions in patients undergoing breast conserving surgery. This study aims to evaluate the feasibility of RFID surgical guidance for nonpalpable breast lesions. This multicenter prospective cohort study was approved by the Institutional Review Board of the University Medical Center Utrecht. Written informed consent is obtained from all participants. Women with nonpalpable, histologically proven in situ or invasive breast cancer, who can undergo breast conserving surgery with RFID localization are considered eligible for participation. An RFID tag is placed under ultrasound guidance, up to 30 days preoperatively. The surgeon localizes the RFID tag with a radiofrequency reader that provides audible and visual real-time surgical guidance. The primary study outcome is the percentage of irradical excisions and reexcision rate, which will be compared to standards of the National Breast Cancer Organisation Netherlands (NABON)(≤ 15% irradical excisions of invasive carcinomas). Secondary outcomes include user acceptability/experiences, learning curve, duration and ease of the placement- and surgical procedure and adverse events. This study evaluates the feasibility of RFID surgical guidance for nonpalpable breast lesions. Results may have implications for the future localization techniques in women with nonpalpable breast cancer undergoing breast conserving surgery. Netherlands National Trial Register, NL8019 , registered on September 12 2019.